20 Years of Medicinal Chemistry – Always Look at the Bright Side (of Life)
This paper summarizes a personal perspective on key learnings from projects the author was involved in over the last 20 years. For example, the discovery of macitentan, the most successful molecule to date from this personal collection, marketed by J&J for the treatment of pulmonary arterial hyp...
Main Author: | Christoph Boss |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2020-08-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/scs/chimia/2020/00000074/f0020007/art00004 |
Similar Items
-
Kinetic properties of 'dual' orexin receptor antagonists at OX1R and OX2R orexin receptors.
by: Gabrielle Elizabeth Callander, et al.
Published: (2013-12-01) -
Orexin receptor antagonists as therapeutic agents for insomnia
by: Ana Clementina Equihua, et al.
Published: (2013-12-01) -
Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant
by: Ishani Landry, et al.
Published: (2020-12-01) -
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
by: Rosenberg R, et al.
Published: (2021-08-01) -
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
by: Suhas Vasaikar, et al.
Published: (2018-02-01)